Ankyra Therapeutics, Inc.

Biotechnology company · Boston, Massachusetts, United States

Ankyra Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $45 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Ankyra Therapeutics at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1811511

What does Ankyra Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $45 million sold (2021).

Frequently asked questions about Ankyra Therapeutics

Where is Ankyra Therapeutics headquartered?

Ankyra Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Ankyra Therapeutics do?

Ankyra Therapeutics, Inc. is a biotechnology company.

When was Ankyra Therapeutics founded?

The earliest incorporation on record for Ankyra Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences